Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Sinopharm has agreed to purchase and distribute at least $3.85 million of the company’s SRS II Systems.
SRS II Systems are designed to be used as a minimally invasive treatment for Gastroesophageal Reflux Disease.
More Articles on Gastroenterology:
Dr. Nanda Kerkar Joins Children’s Hospital LA
Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopy
First Alabama Pediatric Colorectal Clinic Opens
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
